Jakob Löndahl, Lund University - Qepler Summits And Conferences

Jakob Löndahl

Associate Professor
Lund University
Lund, Sweden
Founded in 1666, Lund University, Sweden is one of northern Europe’s oldest, broadest and finest universities and is consistently ranked as one the world’s top 100 universities.

Jakob Löndahl is Associate Professor in aerosol technology at the Department of Design sciences at Lund University and CEO of JP Respiratory Technology.

He has an MSc in engineering physics and in 2009 he received a PhD on experimental analyses of inhaled aerosols.

In 2010-11 he carried out postdoctoral studies on biological aerosol particles at McGill University, Canada, and Aarhus University, Denmark.

Since 2012 his research is mainly focused on health related aspects of aerosol particles, such as exposure to airborne contamination and medical applications of inhaled nanoparticles.

Together with Prof. Per Wollmer he is inventor of the Airspace Dimension Assessment (AiDA), which is a novel instrument for diagnosis of COPD.

Related Sessions:

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 27 Feb 2019
  • Berlin, DE
  • Pharma
Day 2: Thursday, 28 February 2019
BLOCK: FORMULATION, DEVELOPMENT & DESIGN.
CASE STUDY: Experimental investigation of inhaled nanoparticles in the respiratory tract.

His presentation provides an overview on experimental studies of the deposition of inhaled nanoparticles in the respiratory tract.

It also describes some possible benefits of using nanoparticles in medical inhalation applications.

Finally, a new method is presented for detection of respiratory disease based on the deposition of nanoparticles.

View Details